openPR Logo
Press release

Global OTC Pediatric Healthcare Market: Brief Analysis of Products and Application Set to Attain Higher Position Through 2022

07-05-2018 07:41 AM CET | Health & Medicine

Press release from: Fact.MR

Fact.MR

Fact.MR

According to the latest report by Fact.MR, the global market for OTC pediatric healthcare is anticipated to reach close to US$ 10,000 million revenue by 2022 end. The market is expected to experience sluggish growth during the forecast period, 2017 to 2022. Increasing risk of serious side-effects due to OTC medicines based on self-care decision is restricting the parents from choosing OTC drugs for children, thus leading to the decline in OTC pediatric healthcare.

4 Forecast Highlights on Global OTC Pediatric Healthcare Market

1. Among all the other regions, North America is anticipated to surpass US$ 2,000 million revenue by the end of 2022. Increasing consumer awareness to treat minor health issues among children due to a various initiative by the government such as campaign, awareness drive, etc., is one of the factors driving the growth of OTC drugs in the region.

2. Japan and the Middle East and Africa (MEA) are expected to be the least growing market in OTC pediatric healthcare during 2017-2022.

Request Free Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=257

3. Dermatology OTC pediatric products are anticipated to reach close to US$ 3,500 million towards the end of 2022. Global sales of Dermatology OTC pediatric products is expected to gain around one-third revenue share on the global revenues by the end of 2017.

4. Sales of OTC pediatric products will be highest through drug stores/ pharmacies. By the end of 2017, drug stores/pharmacies are expected to account for nearly one-third of the revenue share of the global revenues. Meanwhile, sales of OTC pediatric products will be the least through convenience stores.

High Sales through Drug Stores/ Pharmacies

Accounting for nearly one-third of revenue share in the OTC pediatric healthcare, drug stores/ Pharmacies emerge as one of the most lucrative sales channels. Towards the end of 2022, drug stores/ pharmacies are projected to reach close to US$ 3,200 million revenues. Although, global sales of OTC pediatric medicines through hospital pharmacies is projected to create an incremental opportunity of over US$ 300 million during 2017-2022.

Dermatology- Top-Selling Product

OTC pediatric medicines that fall under dermatology are projected to remain top-selling products in the global OTC pediatric healthcare market between 2017 and 2022. Sale of Dermatology OTC pediatric drugs is expected to bring in nearly US$ 3,500 million revenues towards the end of 2022. Meanwhile, ENT OTC pediatric medicines are anticipated to account for lowest revenue shares. OTC cold and cough medicines are not recommended for children because of the risk of serious side-effects and high chances of developing breathing problems.

Browse Full Report with TOC- https://www.factmr.com/report/257/otc-pediatric-healthcare-market

Competition Tracking

The report also profiles companies that are expected to remain active in the expansion of global OTC pediatric healthcare market through 2022, which include Procter & Gamble, Johnson & Johnson, GlaxoSmithKline Plc, Abbott Laboratories, Amway Corporation, Bayer Aktiengesellschaft, Sanofi, Pfizer, Inc., Reckitt Benckiser Group plc, and Church & Dwight Co., Inc.

Table of Contents:

1. Global OTC Pediatric Healthcare Market – Executive Summary

2. Global OTC Pediatric Healthcare Market Overview

3. Global OTC Pediatric Healthcare Market Analysis and Forecast By Product Type

4. Global OTC Pediatric Healthcare Market Analysis and Forecast By Sales Channel
4.1. Global OTC Pediatric Healthcare Market Size and Forecast By Sales Channel, 2012-2022
4.1.1. Drug store/ Pharmacy OTC Pediatric Healthcare Market Size and Forecast, 2012-2022
4.1.1.1. Revenue (US$ Mn) Comparison, By Region
4.1.1.2. Market Share Comparison, By Region
4.1.1.3. Y-o-Y growth Comparison, By Region
4.1.2. Hospital Pharmacies OTC Pediatric Healthcare Market Size and Forecast, 2012-2022
4.1.2.1. Revenue (US$ Mn) Comparison, By Region
4.1.2.2. Market Share Comparison, By Region
4.1.2.3. Y-o-Y growth Comparison, By Region

5. Global OTC Pediatric Healthcare Market Analysis and Forecast By Region
5.1. Global OTC Pediatric Healthcare Market Size and Forecast, 2012-2022
5.1.1. North America OTC Pediatric Healthcare Market Size and Forecast, 2012-2022
5.1.1.1. Revenue (US$ Mn) Comparison, By Product Type
5.1.1.2. Revenue (US$ Mn) Comparison, By Sales Channel

Buy this Report- https://www.factmr.com/checkout/257/S

About FactMR

FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized Healthcare market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

FactMR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Telephone: +353-1-6111-593
Email: sales@factmr.com
Web: https://www.factmr.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global OTC Pediatric Healthcare Market: Brief Analysis of Products and Application Set to Attain Higher Position Through 2022 here

News-ID: 1110588 • Views:

More Releases from Fact.MR

System Integration Market Is Projected To Rise At A CAGR Of 18.7% Through 2034: Fact.MR Report
System Integration Market Is Projected To Rise At A CAGR Of 18.7% Through 2034: …
The global system integration market is estimated to have a valuation of US$ 401.8 billion in 2024. Projections put the CAGR of the market for the 2024 to 2034 period at a remarkable 18.7%. The market's growth over the forecast period is set to inflate significantly, reaching a projected value of US$ 2,236.6 billion by 2034. The System Integration Industry sales study offers a comprehensive analysis on diverse features including production
Bromelain Market Is Forecasted To Reach US$ 56.2 Million By The End Of 2034: Fact.MR Report
Bromelain Market Is Forecasted To Reach US$ 56.2 Million By The End Of 2034: Fac …
Bromelain market size is pegged at US$ 27.3 million for 2024. Worldwide demand for bromelain is predicted to increase at a robust CAGR of 7.5% and reach a market value of US$ 56.2 million by the end of 2034. The Bromelain Industry sales study offers a comprehensive analysis on diverse features including production capacities, Bromelain demand, product developments, sales revenue generation and Bromelain market outlook across the globe. market research report by
Writing Instruments Market Is Projected To Reach US$ 20.54 Billion By The End Of 2034: Fact.MR Report
Writing Instruments Market Is Projected To Reach US$ 20.54 Billion By The End Of …
The global writing instrument market size is calculated at US$ 14.28 billion for 2024 and is projected to reach US$ 20.54 billion by 2034-end. Worldwide demand for writing instruments is projected to expand at a CAGR of 3.7% from 2024 to 2034. The Writing Instrument Industry sales study offers a comprehensive analysis on diverse features including production capacities, Writing Instrument demand, product developments, sales revenue generation and Writing Instrument market outlook
Lifesciences Data Mining and Visualization Market Rising at 9.1% CAGR to Reach US$ 19.9 Billion by 2033
Lifesciences Data Mining and Visualization Market Rising at 9.1% CAGR to Reach U …
The worldwide data mining and visualization market in the life sciences sector is projected to exceed $8.3 billion by 2023 and is expected to grow at a compound annual growth rate (CAGR) of 9.1%, reaching $19.9 billion by 2033. In 2022, revenue from data mining and visualization in the life sciences amounted for 7% of the total data analytics market. 𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗮 𝗦𝗮𝗺𝗽𝗹𝗲 𝗖𝗼𝗽𝘆 𝗢𝗳 𝗥𝗲𝗽𝗼𝗿𝘁: https://www.factmr.com/connectus/sample?flag=S&rep_id=459 Using data mining and visualization

All 5 Releases


More Releases for OTC

Deadline on Nov. 9th upcoming in Lawsuit for Investors in Harborside Inc. (OTC: …
The Shareholders Foundation announced that a deadline is coming up on November 9, 2020 in the lawsuit filed for certain investors of Harborside Inc. (OTC: HSDEF, OTC: HBORF). Investors who purchased shares of Harborside Inc. (OTC: HSDEF, OTC: HBORF) have certain options and there are strict and short deadlines running. Deadline: November 9, 2020. Harborside Inc. stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to
Investigation for Long-Term Investors in shares of Volkswagen AG (OTC: VWAGY / O …
An investigation on behalf of current long-term investors in shares of Volkswagen AG (OTC: VWAGY / OTC: VLKAF / OTC: VWAPY) was announced over potential breaches of fiduciary duties by certain officers and directors at Volkswagen AG. Investors who purchased shares of Volkswagen AG (OTC: VWAGY / OTC: VLKAF / OTC: VWAPY) and currently hold any of those Volkswagen AG shares have certain options and should contact the Shareholders Foundation at
OTC: VWAGY / OTC: VLKAF / OTC: VWAPY Shareholder Notice: Update in Lawsuit again …
The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in Volkswagen AG (OTC: VWAGY) (OTC: VWAPY) shares. Investors, who purchased shares of Volkswagen AG (OTC: VWAGY) (OTC: VLKAF) (OTC: VWAPY), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. On September 25, 2015, a lawsuit was filed against Volkswagen AG (alleged securities laws violations. The plaintiff claimed that the defendants
OTC Analgesics Market OTC analgesics market is projected to register a steady ex …
About OTC Analgesics Market The global OTC analgesics market is projected to register an above-average CAGR during 2017 to 2022. Global sales of OTC analgesics is estimated to account for nearly US$ 25,000 Mn revenues by 2022-end. Get Sample copy of this Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=75 The trend of using off-label drugs that are affordable and unapproved, but effective in treating diseases, has been witnessing an upsurge over the past few years.
03-14-2018 | Health & Medicine
Fact.MR
OTC Analgesics Market Report 2017-22: Pharmacy to Remain the Most Lucrative OTC …
A fresh study, covering “OTC Analgesics Market Forecast, Trend Analysis & Competition Tracking – Global Review 2017 to 2022” has been broadcasted to wide online repository of Fact MR, which presents deep focus on the healthcare market. This smart study contains precise data that offers a clear insight about market current scenario and future projections for the benefit of readers. Moreover, the study enclosed significant data which tends to make
The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects
ReportsWeb.com has announced the addition of the “Global OTC Drugs Market Research Report 2017” The report focuses on global major leading industry players with information such as company profiles, product picture and specification. GBI Research's latest report, "The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects" discusses trends in the over-the-counter (OTC) pharmaceuticals market and the commercial prospects for switching drugs from prescription-only to OTC status. The report assesses current